Previous 10 | Next 10 |
SAN CARLOS, Calif. , Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the Palmetto MolDX program has proposed a local coverage determination (LCD) for use of Natera's Signatera molecular resi...
SAN CARLOS, Calif. , Aug. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) , a global leader in cell-free DNA testing, today announced that it has now processed more than two million Panorama ® non-invasive prenatal tests (NIPT). Approximately 2,000 Panoram...
The following slide deck was published by Natera, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Natera, Inc. (NTRA) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Michael Brophy – Chief Financial Officer Steve Chapman – Chief Executive Officer Paul Billings – Chief Medical Officer Solomon Moshkevich – General Ma...
Natera (NASDAQ: NTRA ): Q2 GAAP EPS of -$0.48 beats by $0.10 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN CARLOS, Calif. , Aug. 7, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for its second quarter ended June 30, 2019 and provided an update on recen...
AAOI , AGO , AIG , ALB , AMPH , ANGI , ARNA , ASRT , ATO , AVLR , AZPN , BKNG , BREW , CABO , CAI , CCMP , CDE , CECO , CLI , COLL , CPA , CPRX , CSGS , CTL , CVNA , CWH , DAR , DOX , DVAX , EB , ECPG , ENS , ENV , ET , EVRG , FG , FLO , FNV , FOSL , ...
SAN CARLOS, Calif. , Aug. 5, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) , a global leader in cell-free DNA testing, today announced results of a prospective validation study published in the Journal of Clinical Medicine demonstrating 100% accuracy of its Panorama ...
SAN CARLOS, Calif. , July 31, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2019 , after the market close on August 7, 2019 . Natera will host a conference ...
What do you think about when you encounter the phrase “swing trade.” Buy at the bottom of a stock’s trading range and then sell at the top. Yeah, right. Who doesn’t want to do that! Often, though, such aspirations translate to fanciful daydreaming, especially whe...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...